WO1999020259A3 - Compositions containing thiamphenicol and diclofenac - Google Patents

Compositions containing thiamphenicol and diclofenac Download PDF

Info

Publication number
WO1999020259A3
WO1999020259A3 PCT/EP1998/006567 EP9806567W WO9920259A3 WO 1999020259 A3 WO1999020259 A3 WO 1999020259A3 EP 9806567 W EP9806567 W EP 9806567W WO 9920259 A3 WO9920259 A3 WO 9920259A3
Authority
WO
WIPO (PCT)
Prior art keywords
diclofenac
compositions containing
thiamphenicol
containing thiamphenicol
treatment
Prior art date
Application number
PCT/EP1998/006567
Other languages
French (fr)
Other versions
WO1999020259A2 (en
Inventor
Carlo Gazza
Silvia Bernabei
Original Assignee
Fatro Spa
Carlo Gazza
Silvia Bernabei
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fatro Spa, Carlo Gazza, Silvia Bernabei filed Critical Fatro Spa
Priority to AU11543/99A priority Critical patent/AU1154399A/en
Priority to SK568-2000A priority patent/SK5682000A3/en
Publication of WO1999020259A2 publication Critical patent/WO1999020259A2/en
Publication of WO1999020259A3 publication Critical patent/WO1999020259A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

A combination of Thiamphenicol and Diclofenac for use in veterinary medicine in the treatment of infections associated with inflammatory conditions.
PCT/EP1998/006567 1997-10-21 1998-10-16 Compositions containing thiamphenicol and diclofenac WO1999020259A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU11543/99A AU1154399A (en) 1997-10-21 1998-10-16 Compositions containing thiamphenicol and diclofenac
SK568-2000A SK5682000A3 (en) 1997-10-21 1998-10-16 Compositions containing thiamphenicol and diclofenac

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI97A002365 1997-10-21
IT97MI002365A IT1295369B1 (en) 1997-10-21 1997-10-21 COMPOSITION BASED ON TIAMFENICOLO AND DICLOFENAC

Publications (2)

Publication Number Publication Date
WO1999020259A2 WO1999020259A2 (en) 1999-04-29
WO1999020259A3 true WO1999020259A3 (en) 1999-07-08

Family

ID=11378073

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1998/006567 WO1999020259A2 (en) 1997-10-21 1998-10-16 Compositions containing thiamphenicol and diclofenac

Country Status (7)

Country Link
AU (1) AU1154399A (en)
CZ (1) CZ290411B6 (en)
IT (1) IT1295369B1 (en)
PL (1) PL339950A1 (en)
SK (1) SK5682000A3 (en)
TR (1) TR200001075T2 (en)
WO (1) WO1999020259A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
FR2814954B1 (en) * 2000-10-09 2003-02-07 Menarini France NOVEL PHARMACEUTICAL COMPOSITIONS IN THE SPRAY FORM AND THE FORMS THUS PRODUCED
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
US20090238846A1 (en) * 2004-08-31 2009-09-24 Aspion Co., Ltd. S/O type external preparation
UA111147C2 (en) * 2009-11-11 2016-04-11 Байєр Б.В. METHODS AND COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF EXTERNAL OTITIS
CN104224742B (en) * 2014-08-11 2016-08-31 新乡医学院 Thiamphenicol enteric coatel tablets

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912138A (en) * 1986-09-15 1990-03-27 Zambon S.P.A. Pharmaceutical preparation containing thiamphenicol for veterinary use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912138A (en) * 1986-09-15 1990-03-27 Zambon S.P.A. Pharmaceutical preparation containing thiamphenicol for veterinary use

Also Published As

Publication number Publication date
CZ290411B6 (en) 2002-07-17
PL339950A1 (en) 2001-01-15
IT1295369B1 (en) 1999-05-12
AU1154399A (en) 1999-05-10
CZ20001441A3 (en) 2000-10-11
SK5682000A3 (en) 2000-09-12
WO1999020259A2 (en) 1999-04-29
ITMI972365A1 (en) 1999-04-21
TR200001075T2 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
FI973828A0 (en) Compounds and compositions for administering the active ingredients
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
HUP9900312A3 (en) Pharmaceutical compositions, based on etheric oils obtained from plants for use in the human and veterinary medical field
EE9700310A (en) Use of the R-enantiomer of N-propargyl-1-aminoindan, its salts and compositions
EP1600168A3 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorder
IL115563A (en) Substituted benzoxazoles and benzthiazoles and pharmaceutical compositions containing the same
IS1812B (en) Therapeutic compounds, pharmaceutically acceptable salts and compositions containing the compounds, together with their use
HK1020259A1 (en) Composition for use in the treatment and prevention of hyperuricemia.
ZA9811445B (en) Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
HUP9904367A3 (en) Benzamidine derivatives and the use thereof as medicaments with ltb4-antagonistic effect
AU4133997A (en) Pharmaceutical composition for the treatment of syndrome x of reaven
ZA978383B (en) Pharmaceutical compositions comprising amisulpride and therapeutic applications thereof.
AU3745895A (en) Use of gaba antagonists in the treatment of emesis
AU5655696A (en) Pharmaceutical composition containing acetylcysteine, carboc ysteine or erdosteine in combination with a beta 2 agonist a nd an expectorant for the treatment of respiratory tract dis orders
IL136612A0 (en) Phenylaminoalkylcarboxylic acid derivatives and medical compositions containing the same
ZA974270B (en) Pharmaceutical compositions based on diclofenac.
WO1999020259A3 (en) Compositions containing thiamphenicol and diclofenac
WO1998053850A3 (en) Compositions and means for the treatment of burns and other cutaneous traumas
AU2195800A (en) Bis-amido polybiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions
AU3138595A (en) Haloperidol analogs and the use thereof
AU4994996A (en) Composition for the treatment of diarrhea, its use and its preparation
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
AU6720698A (en) Pharmaceutical compositions containing colostrum and the use of colostrum for the treatment of hair loss
AU3061199A (en) Skin treatment compositions and the use thereof
AU7655494A (en) Treatment of laminitis

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/003867

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 5682000

Country of ref document: SK

Ref document number: PV2000-1441

Country of ref document: CZ

Ref document number: 2000/01075

Country of ref document: TR

NENP Non-entry into the national phase

Ref country code: KR

WWP Wipo information: published in national office

Ref document number: PV2000-1441

Country of ref document: CZ

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase
WWG Wipo information: grant in national office

Ref document number: PV2000-1441

Country of ref document: CZ